Professional Documents
Culture Documents
Analyst Dhananjayan J
Contact dhanan12@yahoo.com
Table of Contents (Please enable the macro attached to this file)
Segment >>
Disclaimer >>
FACT SHEET
MARICO LIMITED
NSE: MARICO, BSE: 531642, Exchange: BSE & NSE, MCap: 4,168.61 Crore
Marico Limited is a fast moving consumer goods company. Marico has three business segments: Consumer
Products, which includes consumer product business of Marico Limited and Marico Bangladesh Limited along
with its wholly owned subsidiary, MBL Industries Limited; Skin Care, which includes Kaya Skin Care Limited
and skin care business of Marico Limited in Dubai, and Global Ayurvedics (Sundari LLC.). Consumer products
includes coconut oils, other edible oils, hair oils and other hair care products, fabric care products, soaps and
baby care products. Other products include Skin Care and Global Ayurvedics. In October 2007, Shantih LLC
became a wholly owned subsidiary of the Company. In October 2007, the Company acquired the consumer
division of Enaleni Pharmaceuticals Ltd, through purchase of Enaleni Pharmaceuticals Consumer Division (Pty)
Ltd. In March 2008, the Company announced the divestment of its processed foods business under the brand Sil
to Good Food Group.
Website http://www.maricoindia.com
Price ratio
Price to earnings 25.3
Price to free cash flow na
Price to tangible book value 21.7
Yield Ratio
Dividend yield 1.0%
Earnings yield 4.0%
FCF1 yield na
Return on Assets
Return on operating assets 46.7%
Return on capital invested 94.3%
Operating margins
EBITDA 14.2%
EBIT 12.4%
Net income 8.7%
The above valuation ratios are computed after assuming business acquired and disposed in the LTM financial numbers
published by the company. (Refer QAD sheet)
The above valuation ratios are computed after assuming business acquired and disposed in the LTM financial numbers
published by the company. (Refer QAD sheet)
Conclusion
Capex is more. The divestiture proceeds was not declared by the company. Moreover it is FMCG business that are direct
conditions of the country. Not enough catalyst to drive the value of the business. Tough business with lot of competition. Hard
overvalued.
Our Verdict: May be overvalued. Not enough catalyst to drive the value of the underlying business. Hence not inte
1
80
0.9
77.5
75
0.8
72.5
0.7
70
0.6
67.5
65
0.5
62.5
0.4
60
0.3
57.5
55
0.2
52.5
0.1
50
0 25 7 1 1 2 R R R R R R R R R R R R R R R R R R R R R R R R R R R R R
/ / / 02/ o o o o o o o o o oRow
oo1 oo o oo o oo o oo o oo o oo
291 / / 2 ww w ww w ww w ww w ww w ww w ww w ww w ww w ww
business that are directly related to general economic
h lot of competition. Hard to forecast the growth. May be
CASH FLOW
Net profit before tax and MI as reported 150.08
Tax paid -23.46
Net income 126.62
Adjustments
Depreciation, amortization & impairment 52.19
Profit on sale of assets -3.71
Profit on sale of investments -0.81
Dividend income on investments -0.09
Provision for doubtful debts 0.41
(A) 174.61
Changes in working capital
Inventories -89.18
Sundry debtors -13.00
Loans and advances -12.65
Current liabilities & provisions 108.01
(B) -6.82
Cash from operation (A) + (B) 167.79
Capital expenditure
Purchase of fixed assets -301.66
Sale of fixed assets 1.69
Net capital expenditure -299.97 -299.97 -1.00
BALANCE SHEET
Total assets 561.73 561.73
Investments 0.01
Deferred tax assets 115.15
Cash and bank 42.73
Adv recoverable in cash or in kind 39.64
Operating assets 364.20 364.20
Return on operating assets 46.7% 63.6%
RATIOS
Price INR 68.45 INR 68.45
Mcap 4,168.61 4,168.61
EV 4,376.84 4,376.84 53.00
PE 34.9 25.3
P/FCF1 na na
P/TBV 21.7 21.7
Net debt / EBITDA 0.8
EBIT / Interest expenses 8.2
NOTES
Note 1: Acquisition of Ethnic hair care and health care brands from Enaleni
Date of transaction 31 oct 07
EV - Purchase consideration 53.00
Revenue 53.00
EBITDA 3.31
Pro forma
12/07
1,889.12
268.99
14.2%
35.02
233.98
12.4%
30.99
3.26
206.25
41.25
165.00
0.09
164.91
8.7%
60.90
INR 2.71
-300.97
42.74
303.97
192.37
192.37
INR 3.16
-101.05
INR 68.45
4,168.61
4,429.84
2.3
16.5
18.9
-138.5
25.3
na
21.7
1.0
7.6
INR 0.66
1.0%
4.0%
na
SEGMENT
EBITDA
Consumer products 100.86 158.54 223.94
Growth 57.2% 41.3%
Margin 10.3% 14.5% 15.2%
Others -10.93 -10.82 -1.18
Growth -1.0% -89.1%
Margin -41.5% -20.0% -1.4%
Corporate overheads - - -
Total 89.93 147.72 222.76
Total growth 64.3% 50.8%
Margin 8.9% 12.9% 14.3%
EBIT
Consumer products 89.41 128.04 181.48 138.42 183.92
Growth 43.2% 41.7% 32.9%
Margin 9.1% 11.7% 12.3% 12.6% 13.5%
Others -14.39 -24.99 -10.78 -5.02 -3.09
Growth 73.7% -56.9% -38.4%
Margin -54.6% -46.2% -13.0% -8.5% -3.9%
Corporate overheads - - -
Total 75.02 103.05 170.70 133.40 180.83
Total growth 37.4% 65.6% 35.6%
Margin 7.4% 9.0% 11.0% 11.5% 12.6%
Depreciation
Consumer products 11.45 30.50 42.46
Others 3.46 14.17 9.60
Corporate assets - - -
Total 14.91 44.67 52.06
Capital expenditure
Consumer products 18.37 245.22 304.82
Others 22.63 23.59 7.09
Corporate assets - - -
Total 41.00 268.81 311.91
Assets
Consumer products 307.14 572.10 505.17
Others 66.90 79.04 70.32
Corporate assets 29.08 28.85 150.30
Total 403.12 679.99 725.79
Liabilities
Consumer products 159.30 382.37 452.27
Others 5.79 8.34 66.40
Corporate liabilities 21.11 27.80 14.74
Total 186.20 418.51 533.41
Capital employed
Consumer products 147.84 189.73 52.90 363.15 110.60
Others 61.11 70.70 3.92 99.92 83.81
Corporate liabilities 7.97 1.05 135.56 110.91
Total 216.92 261.48 192.38 463.07 305.32
Disclaimer
Reports prepared by the Value Hunt Research & Analytics contain selected information and do not purport to be comp
available information and data ("the Information") believed to be accurate and complete. Value Hunt Research & Analytics
to be accurate and complete, nor guarantee its accuracy and completeness. Possible errors or incompleteness of the Inform
liability, neither with regard to indirect nor to direct or consequential damages. All rights reserved.
o not purport to be complete. The reports based on publicly
unt Research & Analytics neither do examine the Information
ompleteness of the Information do not constitute grounds for
.